Cargando…
Receptor conversion in distant breast cancer metastases
INTRODUCTION: When breast cancer patients develop distant metastases, the choice of systemic treatment is usually based on tissue characteristics of the primary tumor as determined by immunohistochemistry (IHC) and/or molecular analysis. Several previous studies have shown that the immunophenotype o...
Autores principales: | Hoefnagel, Laurien DC, van de Vijver, Marc J, van Slooten, Henk-Jan, Wesseling, Pieter, Wesseling, Jelle, Westenend, Pieter J, Bart, Joost, Seldenrijk, Cornelis A, Nagtegaal, Iris D, Oudejans, Joost, van der Valk, Paul, van der Groep, Petra, de Vries, Elisabeth GE, van der Wall, Elsken, van Diest, Paul J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096964/ https://www.ncbi.nlm.nih.gov/pubmed/20863372 http://dx.doi.org/10.1186/bcr2645 |
Ejemplares similares
-
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases
por: Jiwa, Laura S, et al.
Publicado: (2014) -
The prognostic effect of DDX3 upregulation in distant breast cancer metastases
por: Heerma van Voss, Marise R., et al.
Publicado: (2016) -
Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011) -
Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011) -
Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
por: Kuijper, Arno, et al.
Publicado: (2005)